CogState Ltd at Tarsier Capital Management MicroCap Leadership Summit (Virtual) Transcript
Cogstate is a neuroscience technology company that makes computerized cognitive tests for diagnosing and assessing neurological diseases, mainly Alzheimer's. These tests are used as clinical endpoints to measure cognition in clinical trials. Cogstate has been used in over 1,800 academic studies and dozens of late-stage clinical trials. They're by far the largest and most validated computerized cognitive tests in the world. The Alzheimer's space is exciting right now because the first-ever disease-modifying therapy for Alzheimer's was approved in June of 2021, Aduhelm. Aduhelm's approval should drive additional R&D and clinical trials work for Alzheimer's drugs as well as support, a newfound need for everyday people to test their cognition at home.
We are honored to have Brad O'Connor, CEO of Cogstate, with us today.
As a reminder, if you have any questions during Brad's presentation, feel free to ask them using the Q&A button on the bottom of the Zoom screen, and we'll get to them after he finishes up his presentation.
Thank you, Brad, for being here. The
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
